"Sequence Listing – Rule 13ter”

<110> ATSO CORPORATE AFFAIRS, S.A. DE C.V. 

<110> CAS BIOTECHNOLOGY, S.C.

<120> ANTISENSE OLIGONUCLEOTIDES OF GLUTATHIONE S-TRANSFERASES FOR 
       CANCER TREATMENT

<130> PCT/MX2020/000003

<140> PCT/MX2020/000003

<141> 2020-01-30

<150> MX2019001389
	
<151> 2019-01-31

<160> 6

<170> PatentIn version 3.5

<210> 1
<211> 25
<212> DNA
<213> Artificial Sequence
<220>
<223> anti-GSTM3 
<400> 1
tagacgactc gcacgacatg gtgac                                              25

<210> 2
<211> 1266
<212> DNA
<213> Homo sapiens
<220>
<223> Human glutathione transferase M3 (GSTM3) mRNA
<400> 2
ctcggaagcc cgtcaccatg tcgtgcgagt cgtctatggt tctcgggtac tgggatattc        60

gtgggctggc gcacgccatc cgcctgctcc tggagttcac ggatacctct tatgaggaga       120

aacggtacac gtgcggggaa gctcctgact atgatcgaag ccaatggctg gatgtgaaat       180

tcaagctaga cctggacttt cctaatctgc cctacctcct ggatgggaag aacaagatca       240

cccagagcaa tgccatcttg cgctacatcg ctcgcaagca caacatgtgt ggtgagactg       300

aagaagaaaa gattcgagtg gacatcatag agaaccaagt aatggatttc cgcacacaac       360

tgataaggct ctgttacagc tctgaccacg aaaaactgaa gcctcagtac ttggaagagc       420

tacctggaca actgaaacaa ttctccatgt ttctgtggaa attctcatgg tttgccgggg       480

aaaagctcac ctttgtggat tttctcacct atgatatctt ggatcagaac cgtatatttg       540

accccaagtg cctggatgag ttcccaaacc tgaaggcttt catgtgccgt tttgaggctt       600

tggagaaaat cgctgcctac ttacagtctg atcagttctg caagatgccc atcaacaaca       660

agatggccca gtggggcaac aagcctgtat gctgagcagg aggcagactt gcagagcttg       720

ttttgtttca tcctgtccgt aaggggtcag cgctcttgct ttgctctttt caatgaatag       780

cacttatgtt actggtgtcc agctgagttt ctcttgggta taaaggctaa aagggaaaaa       840

ggatatgtgg agaatcatca agatatgaat tgaatcgctg cgatactgtg gcatttccct       900

actccccaac tgagttcaag ggctgtaggt tcatgcccaa gccctgagag tgggtactag       960

aaaaaacgag attgcacagt tggagagagc aggtgtgtta aatggactgg agtccctgtg      1020

aagactgggt gaggataaca caagtaaaac tgtggtactg atggacttaa ccggagttcg      1080

gaaaccgtcc tgtgtacaca tgggagttta gtgtgataaa ggcagtattt cagactggtg      1140

ggctagccaa tagagttggc aattgcttat tgaaactcat taaaaataat agagccccac      1200

ttgacactat tcactaaaat taatctggaa tttaaggccc aacattaaac acaaagctgt      1260

attgat                                                                 1266

<210> 3
<211> 1266
<212> DNA
<213> Artificial Sequence
<220>
<223> Human glutathione transferase M3 (GSTM3) mRNA. Reverse complement.
<400> 3
gaatatccca gtacccgaga accatagacg actcgcacga catggtgacg ggcttccgag        60

tctcctcata agaggtatcc gtgaactcca ggagcaggcg gatggcgtgc gccagcccac       120

atttcacatc cagccattgg cttcgatcat agtcaggagc ttccccgcac gtgtaccgtt       180

tgatcttgtt cttcccatcc aggaggtagg gcagattagg aaagtccagg tctagcttga       240

cagtctcacc acacatgttg tgcttgcgag cgatgtagcg caagatggca ttgctctggg       300

gttgtgtgcg gaaatccatt acttggttct ctatgatgtc cactcgaatc ttttcttctt       360

gctcttccaa gtactgaggc ttcagttttt cgtggtcaga gctgtaacag agccttatca       420

ccccggcaaa ccatgagaat ttccacagaa acatggagaa ttgtttcagt tgtccaggta       480

caaatatacg gttctgatcc aagatatcat aggtgagaaa atccacaaag gtgagctttt       540

aagcctcaaa acggcacatg aaagccttca ggtttgggaa ctcatccagg cacttggggt       600

tgttgttgat gggcatcttg cagaactgat cagactgtaa gtaggcagcg attttctcca       660

caagctctgc aagtctgcct cctgctcagc atacaggctt gttgccccac tgggccatct       720

ctattcattg aaaagagcaa agcaagagcg ctgacccctt acggacagga tgaaacaaaa       780

tttttccctt ttagccttta tacccaagag aaactcagct ggacaccagt aacataagtg       840

agggaaatgc cacagtatcg cagcgattca attcatatct tgatgattct ccacatatcc       900

ctagtaccca ctctcagggc ttgggcatga acctacagcc cttgaactca gttggggagt       960

cacagggact ccagtccatt taacacacct gctctctcca actgtgcaat ctcgtttttt      1020

cgaactccgg ttaagtccat cagtaccaca gttttacttg tgttatcctc acccagtctt      1080

caccagtctg aaatactgcc tttatcacac taaactccca tgtgtacaca ggacggtttc      1140

gtggggctct attattttta atgagtttca ataagcaatt gccaactcta ttggctagcc      1200

acagctttgt gtttaatgtt gggccttaaa ttccagatta attttagtga atagtgtcaa      1260

atcaat                                                                 1266

<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence
<220>
<223> anti-GSTP1.
<400> 4 
aatagaccac ggtgtagggc ggcat                                             25

<210> 5
<211> 633
<212> DNA
<213> Homo sapiens
<220>
<223> Human glutathione S-transferase pi (GSTP1) mRNA.
<400> 5  
atgccgccct acaccgtggt ctatttccca gttcgaggcc gctgcgcggc cctgcgcatg        60

ctgctggcag atcagggcca gagctggaag gaggaggtgg tgaccgtgga gacgtggcag       120

gagggctcac tcaaagcctc ctgcctatac gggcagctcc ccaagttcca ggacggagac       180

ctcaccctgt accagtccaa taccatcctg cgtcacctgg gccgcaccct tgggctctat       240

gggaaggacc agcaggaggc agccctggtg gacatggtga atgacggcgt ggaggacctc       300

cgctgcaaat acatctccct catctacacc aactatgagg cgggcaagga tgactatgtg       360

aaggcactgc ccgggcaact gaagcctttt gagaccctgc tgtcccagaa ccagggaggc       420

aagaccttca ttgtgggaga ccagatctcc ttcgctgact acaacctgct ggacttgctg       480

ctgatccatg aggtcctagc ccctggctgc ctggatgcgt tccccctgct ctcagcatat       540

gtggggcgcc tcagtgcccg gcccaagctc aaggccttcc tggcctcccc tgagtacgtg       600

aacctcccca tcaatggcaa cgggaaacag tag                                    633

<210> 6
<211> 633
<212> DNA
<213> Artificial Sequence
<220>
<223> Human glutathione S-transferase pi (GSTP1) mRNA. Reverse complement
<400> 6  
catgcgcagg gccgcgcagc ggcctcgaac tgggaaatag accacggtgt agggcggcat        60

ctgccacgtc tccacggtca ccacctcctc cttccagctc tggccctgat ctgccagcag       120

gtctccgtcc tggaacttgg ggagctgccc gtataggcag gaggctttga gtgagccctc       180

atagagccca agggtgcggc ccaggtgacg caggatggta ttggactggt acagggtgag       240

gaggtcctcc acgccgtcat tcaccatgtc caccagggct gcctcctgct ggtccttccc       300

cacatagtca tccttgcccg cctcatagtt ggtgtagatg agggagatgt atttgcagcg       360

gcctccctgg ttctgggaca gcagggtctc aaaaggcttc agttgcccgg gcagtgcctt       420

cagcaagtcc agcaggttgt agtcagcgaa ggagatctgg tctcccacaa tgaaggtctt       480

atatgctgag agcaggggga acgcatccag gcagccaggg gctaggacct catggatcag       540

cacgtactca ggggaggcca ggaaggcctt gagcttgggc cgggcactga ggcgccccac       600

ctactgtttc ccgttgccat tgatggggag gtt                                    633

